SCHEMBL24640783

SCHEMBL24640783

CC(C)N1CCN2c3ncccc3O[C@H]2C1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 6/20 0.38
ADRA2A P08913 2/20 0.34
ADRA2B P18089 2/20 0.34
ADRA2C P18825 2/20 0.34
CYP1A2 P05177 1/20 0.34
CHRM2 P08172 1/20 0.34
HTR1A P08908 1/20 0.34
CYP2D6 P10635 1/20 0.34
CHRM1 P11229 1/20 0.34
CYP2C9 P11712 1/20 0.34
TSHR P16473 1/20 0.34
DRD1 P21728 1/20 0.34
HTR2A P28223 1/20 0.34
HTR2C P28335 1/20 0.34
CYP2C19 P33261 1/20 0.34
HTR7 P34969 1/20 0.34
ADRA1A P35348 1/20 0.34
HRH1 P35367 1/20 0.34
DRD3 P35462 1/20 0.34
HTR2B P41595 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24640161 1.00 HRH3 (0.38) HRH3ADRA2AADRA2BADRA2CCYP1A2
SCHEMBL24763844 0.79 HTR2B (0.40) HRH3ADRA2AADRA2BADRA2CCYP1A2
SCHEMBL24640808 0.79 LTA4H (0.37) HRH3ADRA2AADRA2BADRA2CCYP1A2
SCHEMBL24640717 0.79 LTA4H (0.37) HRH3ADRA2AADRA2BADRA2CCYP1A2
SCHEMBL24640038 0.77 SOS1 (0.41) HRH3HTR2AHTR2CHTR2BPDE10A
SCHEMBL24640702 0.77 SOS1 (0.41) HRH3HTR2AHTR2CHTR2BPDE10A
SCHEMBL24640703 0.77 SOS1 (0.41) HRH3HTR2AHTR2CHTR2BPDE10A
SCHEMBL24639936 0.71 HTR2A (0.42) HRH3ADRA2AADRA2BADRA2CCYP1A2
SCHEMBL24640622 0.71 HRH3 (0.38) HRH3ADRA2AADRA2BADRA2CCYP1A2
SCHEMBL24640708 0.71 HRH3 (0.38) HRH3ADRA2AADRA2BADRA2CCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022170974-A1 TRICYCLIC DERIVATIVES USEFUL AS PARP7 INHIBITORS JACOBIO PHARMACEUTICALS CO., LTD. (CN) 2022-08-18 WO disclosed